Olaparib-bodipy FL

DB16263InvestigationalSmall molecule

Olaparib-bodipy FL is under investigation in clinical trial NCT03085147 (A Dye for the Detection of Cancer of the Tongue and Mouth).

Mechanism: Pharmacologically active on Poly [ADP-ribose] polymerase 1
Curator reviewed
Formula / weight: C₃₄H₃₂BF₃N₆O₃ · 640.47 g/mol (avg)
Also known as: PARPi-FL

Resolves to

Compound

UNIIZMX54372EHCAS1380359-84-1

Structure

InChIKeyIGUTVNUEFKPBGK-UHFFFAOYSA-NSMILESCC1=CC(C)=C2C=C3C=CC(CCC(=O)N4CCN(CC4)C(=O)C4=C(F)C=CC(CC5=NNC(=O)C6=CC=CC=C56)=C4)=[N+]3[B-](F)(F)N12

Targets

P09874PARP1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Olaparib-bodipy FL, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account